GrantDSchmitMD

PubMed

• 60 citations
  Predicting Renal Cryoablation Complications: New Risk Score Based on Tumor Size and Location and Patient History
  Grant D. Schmit, Louis A. Schenck, R. Houston Thompson, Stephen A. Boorjian, A. Nicholas Kurup
  Radiology. 2014-05-07
• 24 citations
  Percutaneous cryoablation of anterior renal masses: technique, efficacy, and safety.
  Grant D. Schmit, Thomas D. Atwell, Bradley C. Leibovich, Matthew R. Callstrom, Anil N. Kurup
  AJR. American Journal of Roentgenology. 2010-12-01
• 58 citations
  Percutaneous Renal Cryoablation: Local Control at Mean 26 Months of Followup
  Thomas D. Atwell, Matthew R. Callstrom, Michael A. Farrell, Grant D. Schmit, David A. Woodrum
  The Journal of Urology. 2010-10-01

Journal Articles

• MC2 System for Predicting Cryoblation Complications  
  Schmit GD, Schenck LA, Thompson RH, Boorjian SA, Kurup AN, Weisbrod AJ, Kor DJ, Callstrom MR, Atwell TD, Carter RE, Radiology, 1/1/2014
• To the editor  
  Psutka SP, Moynagh M, Schmit G, Tollefson MK, J Urol, 1/1/2014
• MRI after technically successful renal cryoablation: Early contrast enhancement as a common finding  
  Porter CA IV, Woodrum DA, Callstrom MR, Schmit GD, Misra S, Charboneau JW, Atwell TD, J Endourol, 1/1/2010

Books/Book Chapters

• Mayo Clinic gastrointestinal imaging review 
  Johnson CD, Schmit GDMayo Clinic Scientific Press, Rochester, MN2005

Abstracts/Posters

• Recurrence and survival outcomes following percutaneous thermal ablation of oligometastatic melanoma
  White ML, Atwell TD, Kurup AN, Schmit G, Carter R, Geske J, Kottschade LA, Block MS, Callstrom MR, Markovic S, J Clin Oncol, 1/20/2015
• The Effects of Aspirin Therapy on Renal Transplant Biopsy Bleeding Complications
  Schmit GD, 101st Scientific Assembly and Annual Meeting of the Radiological Society of North America, Chicago, IL, 1/1/2015
• Percutaneous Ablation of Oligometastatic Prostate Cancer: Oncologic Outcomes and Safety
  Schmit GD, 101st Scientific Assembly and Annual Meeting of the Radiological Society of North America, Chicago, IL, 1/1/2015
• Clinical and radiographic predictors of the need for resection of the inferior vena cava during nephrectomy for patients with renal cell carcinoma and caval tumor thro...
  Psutka SP, Boorjian SA, Thompson RH, Schmit GD, Schmitz JJ, Bower TC, Stewart SB, Lohse C, Cheville JC, Leibovich BC, BJU Int, 1/1/2014
• Percutaneous Image-guided Ablation of Metastatic Renal Cell Carcinoma
  Welch BT, Callstrom MR, Morris JM, Kurup AN, Schmit GD, Atwell TD, Weisbrod AJ, Kohli M, Costello B, Lohse C, Boorjian S, Thompson R, RSNA Scientific Assembly and Annual Meeting, 1/5/2013
• Cryoablation of Perineural Musculoskeletal Tumors: Use of Intraprocedural Motor Evoked Potential (MEP) Monitoring to Improve Safety
  Kurup AN, Morris JM, Schmit GS, Atwell TD, Weisbrod AJ, Callstrom MR, Boon AJ, Wass CT, Rose P, Carter R, RSNA Scientific Assembly and Annual Meeting, 1/2/2013
• Outcomes Following Percutaneous Cryoablation of Renal Masses 4.1-70 cm
  Vlaminck JJ, Schmit GD, Kurup AN, Weisbrod AJ, Callstrom MR, Atwell TD, McDonald RJ, Thompson R, Boorjian S, RSNA Scientific Assembly and Annual Meeting, 1/1/2013
• Pathologic findings in needle core biopsies of renal tumors treated with ablation therapy
  Jimenez RE, Lohse CM, Atwell TD, Schmit GD, Kurup AN, Cheville JC, Lab Invest, 1/1/2013
• Recognizing locally recurrent renal tumor after percutaneous cryoablation: normal findings, pitfalls, and case studies
  Goss BC, Weisbrod AJ, Schmit GD, Kurup AN, Callstrom MR, Atwell TD, Thompson R, Boorjian S, Radiological Society of North America Scientific Assembly and Annual Meeting Program, Chicago, IL, 1/30/2012
• Percutaneous Cryoablation of Central Renal Masses
  Weisbrod AJ, Schmit GD, Kurup AN, Callstrom MR, Boorjian S, Atwell TD, Thompson R, Radiological Society of North America, 1/29/2012
• Percutaneous Renal Cryoablation Following Partial Nephrectomy: Technical Feasibility, Complications and Outcomes in Treatment of 49 Patients
  Hegg RM, Schmit GD, Kurup AN, Weisbrod AJ, Carter R, Atwell TD, Callstrom MR, Geske JR, Thompson R, Boorjian S, Radiological Society of North America, 1/29/2012
• Percutaneous Cryoablation of Musculoskeletal Oligometastatic Disease with Curative Intent
  McMenomy BP, Kurup AN, Johnson GB, Carter R, McWilliams R, Callstrom MR, Markovic S, Atwell TD, Schmit GD, Maus TP, Welch TJ, Morris JM, Woodrum DA, Fleming CJ, Nichol..., Radiological Society of North America, 1/26/2012
• Percutaneous ablation of renal masses measuring 3.0 cm and smaller: outcomes following RFA and cryoablation
  Atwell T, Mandrekar J, Schmit G, Kurup A, Weisbrod A, Chow G, Callstrom M, Leibovich B, Boorjian S, Am J Roentgenol, 1/1/2012
• The A.B.L.A.T.E. Nephrectomy Score: A Comprehensive Standardized System for Quantitating Renal TumorMorphology Specific to Percutaneous Ablation
  Schmit G, Carter R, Weisbrod A, Kurup A, Callstrom M, Atwell T, et al, RSNA, 1/1/2012
• Simultaneous comparison of gallbladder ejection fractions measured by 3D ultrasound and cholescintigraphy
  Schmitz JJ, Schmit GD, Meixner DD, Knudsen JM, Callstrom MR, Collins D, Carter R, Radiological Society of North America Scientific Assembly and Annual Meeting Program, Oak Brook, IL, 1/1/2011
• Neuroanatomic considerations in percutaneous tumor ablation
  Kurup AN, Atwell TD, Morris JM, Murthy NS, Schmit GD, Woodrum DA, Weisbrod AJ, Callstrom MR, Radiological Society of North America, 1/1/2011
• Comparison of 3D ultraound with magnetic resonance imaging of three-dimensional dynamic gallbladder contraction during Sincalide infusion
  Reisiger KE, Knudsen JM, Topazian MD, Meixner DD, Lahr B, Schmit GD, Radiological Society of North America Scientific Assembly and Annual Program, Oak Brook, IL, 1/1/2011
• Transarterial chemoembolization (TACE) improved survival in unresectable intrahepatic cholangiocarcinoma
  Chaiteerakij R, Schmit G, Mettler TA, Andrews J, Roberts LR, Hepatology, 1/1/2010
• Hydrodisplacement in the percutaneous cryoablation of 36 renal tumors
  Bodily K, Atwell T, Farrell M, Callstrom M, Schmit G, Charboneau W, Abdominal Radiology, Maui, HI, 1/20/2009
• Percutaneous renal cryoablation; considerations in lesion selection and treatment technique
  Kurup AN, Atwell TD, Callstrom MR, Schmit GD, Fleming CJ, Charboneau JW, et al, Radiological Society of North America Scientific Assembly and Annual Meeting Program, Oak Brook, IL, 1/1/2009
• Percutaneous cryoablation: midterm results of tumor treatment
  Atwell TD, Farrell MA, Schmit GD, Callstrom MR, Woodrum DA, Charboneau JW, Radiological Society of North America Scientific Assembly and Annual Meeting Program, Oak Brook, IL, 1/1/2009
• 3T MRI in the staging for rectal cancer
  Williams S, Fidler J, Schmit GD, Hough D, Fletcher JG, 16th annual meeting of the International Society of Magnetic Resonance in Medicine, Ontario, Canada, 1/9/2008
• Hydrodisplacement in cryoablation of renal tumors: the Mayo Clinic experience
  Bodily K, Atwell T, Farrell M, Callstrom M, Schmit G, Charboneau W, Radiological Society of North America, Chicago, IL, 1/1/2008
• Feasibility and application of 3-dimensional ultrasound for measurement of gastric volumes in healthy adults and adolescents
  Manini ML, Burton D, Meixner D, Eckert D, Callstrom M, Schmit G, El-Youssef M, Camilleri M, Am J Gastroenterol; Digestive Disease Week, San Diego, CA, 1/1/2008
• Percutaneous cryoablation of 92 renal tumors: technical success, complications, and short-term outcomes
  Atwell TD, Farrell MA, Callstrom MR, Lewis BD, Schmit GD, Charboneau JW, et al, Radiological Society of North America Scientific Assembly and Annual Meeting Program, Oak Brook, IL, 1/1/2007
• Join now to see all

Lectures

• Percutaneous Ablation of Oligometastatic Prostate Cancer: Oncologic Outcomes and Safety 
  Chicago, IL - 1/1/2015
• Single Institution Review of Percutaneous Cryoablation in the Horseshoe Kidney: An Initial Experience 
  Chicago, IL - 1/1/2015
• Contemporary Results with Percutaneous Ablation 
  Kohala Coast, HI - 1/1/2014
• Interventional Oncology Technology 
  New York, NY - 1/1/2014
• Therapy Planning, Guidance and Endpoint Determination for Tumor Ablation 
  New York, NY - 1/1/2014
• Management of renal tumors: the role of percutaneous ablation 
  Maui, HI - 1/1/2013
• Percutaneous Renal Cryoablation in Obese and Morbidly Obese Patients 
  Chicago, IL - 1/1/2013
• The A.B.L.A.T.E. nephometry score: a comprehensive standardized system for quantitating renal tumor morphology specific to percutaneous ablation 
  Chicago, IL - 1/1/2012
• Percutaneous Ablation of Primary and Metastatic Liver Tumors 
  Phoenix, AZ - 1/1/2011
• The reasons for cryoablation in the kidney--yes and buts 
  Trieste, Italy - 1/1/2011
• Renal ryoablation: Advanced techniques and potential complications 
  Phoenix, AZ - 1/1/2011
• Cryoablation of Renal Masses I 
  Phoenix, AZ - 1/1/2010
• Cryoablation of Renal Masses II 
  Phoenix, AZ - 1/1/2010
• Ablation of Hepatocellular Carcinoma 
  Phoenix, AZ - 1/1/2010
• Question and Answer Panel Discussion: Interventional Radiology 
  Phoenix, AZ - 1/1/2010
• MRI of the liver for the hepatobiliary clinician 
  Rochester, MN - 1/1/2010
• Multimodality imaging of diffuse liver disease 
  Maui, HI - 1/1/2008
• Percutaneous ablation of hepatocellular carcinoma 
  Rochester, MN - 1/1/2008
• GI Radiology oral board review 
  Rochester, MN - 1/1/2008
• Multimodality imaging of the liver for HCC 
  Rochester, MN - 1/1/2008
• Multimodality imaging of the cirrhotic liver 
  Rochester, MN - 1/1/2008
• MRI of liver masses 
  Rochester, MN - 1/1/2007
• Mock Radiology oral boards 
  Rochester, MN - 1/1/2007
• The percutaneous cryoablation of 92 renal tumors: technical success and short-term outcomes 
  Chicago, IL - 1/1/2007
• Current Imaging of Pancreatic Adenocarcinoma 
  Vancouver, Canada - 1/1/2006
• Join now to see all